"Fast Money" producer Leanne Miller tests the dating app Tinder and goes on a date with an Australian comedian.» Read More
"If the Fed doesn't deliver, gold will be under pressure," says Yra Harris, Praxis Trading, with a preview of the market-moving activities traders will be watching ahead of the opening bell.
A look at the U.S. markets ahead of the open, with CNBC's Kelly Evan, including whether the Fed will announce additional economic easing when it wraps a two-day meeting this afternoon.
Former Minnesota Governor Jesse Ventura explains why he thinks U.S. politics and the government has become its own 'gangsta's paradise.'
A new study from RBC Capital and Capgemini says the past year has been tough on not only the poor, but the rich, reports CNBC's Robert Frank. Hugh Hewitt, The Hugh Hewitt Show host, weighs in.
As the euro zone crisis deepens and global recession fears linger, how can investors make money in this environment? Russ Koesterich, BlackRock iShares Group; Michael Ozanian, Forbes Magazine; and Dick Bove, Rochdale Securities, weigh in.
CNBC's Bertha Coombs reports no deal was made between Chairman Darrell Issa and Attorney General Eric Holder on the ATF documents, and also reports on conflicting news that former Egyptian president Hosni Mubarak is "near death" in a Cairo hospital.
Discussing whether our planet is headed for disaster if we do not combat global warming right now, with Rael Jean Isaac, author of "Roosters of the Apocalyspse," and Dan Weiss, Center for American Progress.
Should Congress aspire to writing lots and lots of laws, or are they there to monitor the economy? Kevin Williamson, National Review and Jimmy Williams, Democratic strategist, share their opinions. "It's a dumb metric," says Williamson.
The last time Congress was this unproductive was during the 104th Congress, reports CNBC's Bertha Coombs. Radio show host Hugh Hewitt and Conference Chairman Jeb Hensarling (R-TX), weigh in.
Mad Money host Jim Cramer shares his final thoughts of the day.
Ron Cohen, Acorda Therapeutics president & CEO, offers insight on just how much potential his company's multiple sclerosis drug "AMPYRA" has in the pharmaceutical market.
How do investors know the difference between a horrible decline and a buyable pullback? Mad Money host Jim Cramer, takes a look at Nike's 10% decline in the last 6 weeks as an example.
Jean-Jacques Bienaime, BioMarin Pharmaceutical CEO, discusses his company's efforts to develop treatment products for Lysosomal Storage Disorders. "We are the opposite of big pharma, we look at a significant improvement in a small patient population," says Bienaime.
Mad Money host Jim Cramer says today's rally was a glimpse of what could happen if the European mess ever gets resolved.
The Fast Money traders explain why they have chosen Applied Materials as their "trade of the day."
Microsoft unveiled its "Surface" tablet, and David Pogue, New York Times, discusses how he thinks the product will fare in the tablet industry; and Andy Barish, Jefferies analyst, weighs in on the impact low commodity prices might have on specialty coffee companies.
Dennis Gartman of The Gartman Letter, discusses what gold equities, like big mining stocks, can tell investors about the market's next move, and the decline in U.S. cattle prices.
Walgreen announced its purchase of 45% of Alliance Boots, and Fast Money trader Karen Finerman of Metropolitan Capital Advisors, discusses why she sees red flags in the deal. Caroline Levy, CLSA analyst, shares her opinions on whether Monster Beverage can sustain its growth.
The VIX continues its decline and has now dropped 17% over the past week, with the Fast Money traders; and Larry McMillan, McMillan Analysis Corporation president, explains how he is using options to find strong buys in the S&P 500.
CNBC's Sharon Epperson discusses the day's activity in the commodities markets and looks at where oil and precious metals are likely headed tomorrow.